Results
Astec LifeSciences Q2 FY27 Net Loss Widens to ₹37.4 Crore
Astec LifeSciences reported Q2 FY27 consolidated loss after tax of ₹37.4 crore, worsening from ₹24.4 crore loss in Q2 FY26 due to agrochemical market weakness.
Total income declined 3% YoY to ₹72.6 cr
